Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis

被引:136
作者
Lei, BF [1 ]
DeLeo, FR
Hoe, NP
Graham, MR
Mackie, SM
Cole, RL
Liu, MY
Hill, HR
Low, DE
Federle, MJ
Scott, JR
Musser, JM
机构
[1] NIAID, Rocky Mt Labs, Lab Human Bacterial Pathogenesis, Hamilton, MT 59840 USA
[2] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA
[3] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA
[4] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT USA
[5] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA
[6] Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada
[7] Univ Toronto, Toronto, ON, Canada
关键词
D O I
10.1038/nm1201-1298
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Microbial pathogens must evade the human immune system to survive, disseminate and cause disease. By proteome analysis of the bacterium Group A Streptococcus (GAS), we identified a secreted protein with homology to the alpha -subunit of Mac-1, a leukocyte beta (2) integrin required for innate immunity to invading microbes. The GAS Mac-1-like protein (Mac) was secreted by most pathogenic strains, produced in log-phase and controlled by the covR-covS two-component gene regulatory system, which also regulates transcription of other GAS virulence factors. Patients with GAS infection had titers of antibody specific to Mac that correlated with the course of disease, demonstrating that Mac was produced in vivo. Mac bound to CD16 (Fc gamma RIIIB) on the surface of human polymorphonuclear leukocytes and inhibited opsonophagocytosis and production of reactive oxygen species, which resulted in significantly decreased pathogen killing. Thus, by mimicking a host-cell receptor required for an innate immune response, the GAS Mac protein inhibits professional phagocyte function by a novel strategy that enhances pathogen survival, establishment of infection and dissemination.
引用
收藏
页码:1298 / 1305
页数:8
相关论文
共 38 条
[1]   Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995 [J].
Beall, B ;
Facklam, R ;
Hoenes, T ;
Schwartz, B .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (05) :1231-1235
[2]   The transcriptional responses of respiratory epithelial cells to Bordetella pertussis reveal host defensive and pathogen counter-defensive strategies [J].
Belcher, CE ;
Drenkow, J ;
Kehoe, B ;
Gingeras, TR ;
McNamara, N ;
Lemjabbar, H ;
Basbaum, C ;
Relman, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (25) :13847-13852
[3]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[4]  
BROWN G, 1988, ANTIBODIES, V1, P81
[5]   Identification of rgg-regulated exoproteins of Streptococcus pyogenes [J].
Chaussee, MS ;
Watson, RO ;
Smoot, JC ;
Musser, JM .
INFECTION AND IMMUNITY, 2001, 69 (02) :822-831
[6]  
CORBI AL, 1988, J BIOL CHEM, V263, P12403
[7]   Pathogenesis of group A streptococcal infections [J].
Cunningham, MW .
CLINICAL MICROBIOLOGY REVIEWS, 2000, 13 (03) :470-+
[8]   New protective antigen of group A streptococci [J].
Dale, JB ;
Chiang, EY ;
Liu, SY ;
Courtney, HS ;
Hasty, DL .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) :1261-1268
[9]  
DeLeo FR, 1999, J IMMUNOL, V163, P6732
[10]   ICAM-1 (CD54) - A COUNTER-RECEPTOR FOR MAC-1 (CD11B CD18) [J].
DIAMOND, MS ;
STAUNTON, DE ;
DEFOUGEROLLES, AR ;
STACKER, SA ;
GARCIAAGUILAR, J ;
HIBBS, ML ;
SPRINGER, TA .
JOURNAL OF CELL BIOLOGY, 1990, 111 (06) :3129-3139